Trust Company of Vermont’s BlackRock Health Sciences Trust BME Stock Holding History

Trust Company of Vermont’s Portfolio BME Stock Details BME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$20.6K	Buy	+500	New	+$19.7K	﹤0.01%	741

Other funds holding BME

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

NRW

Nova R Wealth Overland Park, Kansas $343M AUM 17.7% 1-Year Est. Return

1CP

1607 Capital Partners Richmond, Virginia $1.39B AUM 8.35% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

KIM

Karpus Investment Management Pittsford, New York $3.21B AUM 6.83% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Trust Company of Vermont's BME Position: Q4 2025 in Review

Trust Company of Vermont opened a new position in BlackRock Health Sciences Trust (BME) in Q4 2025: 500 shares worth $20.6K. The stake represents ﹤0.01% of the portfolio and ranks #741 among its holdings.

77 funds tracked by Wall St. Rank hold BME as of Q4 2025.

Trust Company of Vermont held 500 shares of BlackRock Health Sciences Trust worth $20.6K as of Q4 2025.
BlackRock Health Sciences Trust was a new Trust Company of Vermont position in Q4 2025.
BlackRock Health Sciences Trust made up ﹤0.01% of Trust Company of Vermont's portfolio in Q4 2025, its #741 holding.
77 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2025.

Based on Trust Company of Vermont's 13F filing for Q4 2025, filed 16 Jan 2026.